Publication | Closed Access

An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: Structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines

Tumor BiologyMedicinal ChemistryAnticancer ActivitiesMedicinePharmacologyVitro Comparative AssessmentAnti-cancer AgentNew TriphenyltinDrug DevelopmentOncologyRadiation OncologyCancer ResearchDrug Discovery